Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results
Abstract Number: A6
PERSPECTIVES ABOUT COVID-19 AMONG OBESE AFRICAN AMERICANS HOSPITALIZED DURING THE PANDEMIC
SHM Converge 2022
Background: Obesity increases the risk of severe illness, hospitalizations, and death from most acute illnesses – particularly infectious diseases. (1,2) African American communities have been greatly affected by the COVID-19 pandemic and are disproportionately impacted by the obesity epidemic in this country. (3, 4) However, little is known of their knowledge and attitudes related to […]
Abstract Number: A7
SAFETY OF INVESTIGATIONAL MICROBIOTA-BASED LIVE BIOTHERAPEUTIC RBX2660 IN INDIVIDUALS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: DATA FROM 5 PROSPECTIVE CLINICAL STUDIES
SHM Converge 2022
Background: Microbiota-based treatments have shown promise to reduce recurrence for recurrent Clostridioides difficile infections (rCDI), but consistent and reliable safety data are needed to support regulatory approvals and broaden patient access. Here we provide cumulative safety data from 5 prospective clinical studies evaluating RBX2660—a standardized, microbiota-based investigational live biotherapeutic—for reducing rCDI. Methods: This analysis included […]
Abstract Number: B6
COMPARISON OF HOSPITALIST MORALE IN A COVID ALTERNATE CARE SITE TO CONVENTIONAL HOSPITALS IN MARYLAND
SHM Converge 2022
Background: Provider morale is an important concern for hospitals, particularly during the COVID pandemic. Data from hospitals and alternate care sites (ACSs) have found low morale in hospitalists and nurses working with COVID patients. We compared hospitalist morale at a COVID ACS to regional conventional hospitals using the validated Hospitalist Morale Index (HMI). Methods: Using […]
Abstract Number: C6
COVID-19 MORTALITY AMONG INHALED CORTICOSTEROIDS USERS – META-ANALYSIS
SHM Converge 2022
Background: The Coronavirus disease 2019 (COVID-19) pandemic caused a staggering 200 million cases with over 4 million deaths globally as of August 2021. COVID-19 is associated with lung inflammation and pulmonary fibrosis. Inhaled corticosteroids (ICS) are used to improve lung function by reducing inflammation, edema, mucus secretion, and inhibiting various cytokine activities. However, there is […]
Abstract Number: E6
MICROBIOTA-BASED BIOTHERAPEUTIC RBX2660 IMPROVES CLOSTRIDIOIDES DIFFICILE INFECTION OUTCOMES IN A REAL-WORLD POPULATION: A RETROSPECTIVE STUDY OF USE UNDER ENFORCEMENT DISCRETION
SHM Converge 2022
Background: Recurrent Clostridioides difficile infection (rCDI) is an urgent public health threat. RBX2660 is a standardized, stabilized, investigational microbiota-based live biotherapeutic that has been evaluated in 5 prospective clinical trials. Eligibility criteria in clinical trials are often narrowly defined, excluding broader patient populations. Herein, we report a retrospective analysis of safety and efficacy of RBX2660 […]
Abstract Number: F6
INCIDENCE OF ACUTE ISCHEMIC STROKE AND TIA IN HOSPITALIZED COVID19-POSITIVE PATIENTS COMPARED TO INFLUENZA-POSITIVE PATIENTS
SHM Converge 2022
Background: Of the many complications associated with COVID-19 infection, hypercoagulable states with subsequent thrombosis are some of the most feared implications. When trying to uncover a potential relationship between COVID-19 infection and risk for cerebrovascular ischemic events, knowing whether there is an increased risk for these events in those with other respiratory viral pathogens at […]
Abstract Number: G6
EFFICACY OF METHYLNALTREXONE IN PATIENTS WITH ADVANCED ILLNESS AND OPIOID-INDUCED CONSTIPATION REFRACTORY TO CONVENTIONAL LAXATIVES: IMPACT OF BASELINE LAXATIVE USE
SHM Converge 2022
Background: Methylnaltrexone (MNTX) is a peripherally acting µ-opioid receptor antagonist indicated for opioid-induced constipation (OIC). We evaluated whether baseline use of laxatives, including stimulants, osmotic agents, stool softeners, or combinations thereof affects the efficacy and safety of MNTX. Methods: This post hoc analysis included pooled data from 2 multicenter, randomized, double-blind, placebo (PBO)-controlled, institutional review […]
Abstract Number: H5
THE CONTINUED IMPACT OF COVID-19 ON HOSPITALIST BURNOUT: QUALITATIVE RESULTS FROM THE HOSPITAL MEDICINE REENGINEERING NETWORK PROVIDER WELLNESS WORKGROUP
SHM Converge 2022
Background: The HOMERuN (HOspital MEdicine Reengineering Network) Provider Wellness Workgroup, a national collaboration of academic hospitalist institutions, has been studying the landscape of hospitalist wellness during the COVID-19 pandemic. Burnout among hospital medicine clinicians during the peak of the COVID-19 pandemic has been well-described. As we enter a different phase of the pandemic, our workgroup […]
Abstract Number: H6
COMPARISON OF LUNG SCANNING PROTOCOLS WITH POINT-OF-CARE ULTRASOUND IN HOSPITALIZED PATIENTS WITH COVID-19
SHM Converge 2022
Background: Introduction: Point-of-care ultrasound (POCUS) expediently detects the pulmonary manifestations of COVID-19 and is predictive of patient outcomes. Although lung POCUS can be used in the diagnosis and management of patients hospitalized with COVID-19, there are no standardized scanning protocols. Furthermore, it is not known how much scanning is needed to sufficiently rule-in the pulmonary […]
Abstract Number: I5
AVAILABILITY OF MEDICATIONS FOR SUBSTANCE USE DISORDERS IN STATE PRISONS IN NEW MEXICO
SHM Converge 2022
Background: Hospitalists often care for patients who have substance use disorders as well as patients who are incarcerated. Availability of medications for substance use disorders (MSUD) varies based on state law and access varies based on facility, city, and county. Since hospitalization presents a unique opportunity to prevent negative consequences of substance use disorders, it […]
1 2 3 4 Next ›
  • This Week

  • This Month

  • All Time

  • This Week

  • A Patient’s Presentation of Persistent Sweet Taste in Her Mouth Leads to a Diagnosis of Small Cell Lung Cancer
  • BLOWING SMOKE: VAPING-ASSOCIATED LUNG INJURY PRESENTING AS ABDOMINAL PAIN
  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • Cannabis Withdrawal Induced Hypertensive Urgency
  • This Month

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • BLOWING SMOKE: VAPING-ASSOCIATED LUNG INJURY PRESENTING AS ABDOMINAL PAIN
  • A Patient’s Presentation of Persistent Sweet Taste in Her Mouth Leads to a Diagnosis of Small Cell Lung Cancer
  • Cannabis Withdrawal Induced Hypertensive Urgency
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • All Time

  • PECULIAR PRESENTATION OF VERTIGO IN HYPOTHYROIDISM
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
  • A Newborn with Bilateral Shoulder Dimples: Case Report and a Review of Literature
© Society of Hospital Medicine | All Rights Reserved
Page load link
Go to Top